dipyridamole has been researched along with khellin in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (71.43) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Hashimoto, K; Kimura, T; Kubota, K; Oguro, K | 1 |
Hashimoto, K; Oguro, K | 1 |
Messini, M | 1 |
HELMY, R | 1 |
RUBTSOV, MV | 1 |
7 other study(ies) available for dipyridamole and khellin
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Effects of various coronary vasodilators on myocardial oxygen consumption.
Topics: Animals; Benzopyrans; Butyrates; Coronary Circulation; Coumarins; Dicarboxylic Acids; Diethylamines; Dipyridamole; Dogs; Dose-Response Relationship, Drug; Female; Glycolates; Heart; Heart Rate; Isoproterenol; Khellin; Lidoflazine; Male; Myocardium; Nitrobenzenes; Nitroglycerin; Oxygen Consumption; Papaverine; Prenylamine; Pyridines; Triazoles; Vasodilator Agents; Verapamil | 1973 |
Quantitative and comparative studies of pharmacological features in the coronary, femoral and renal circulations with different coronary vasodilators.
Topics: Animals; Coronary Vessels; Coumarins; Dicarboxylic Acids; Dipyridamole; Dogs; Female; Femoral Artery; Femoral Vein; Glycolates; Khellin; Lidoflazine; Male; Nitrobenzenes; Nitroglycerin; Papaverine; Prenylamine; Pyridines; Pyrimidines; Renal Artery; Renal Veins; Vasodilator Agents; Verapamil | 1974 |
[Therapy of angina pectoris. 3. Papaverine, xanthine and other drugs].
Topics: Angina Pectoris; Dipyridamole; Humans; Iproniazid; Khellin; Lidoflazine; Papaverine; Prenylamine; Verapamil; Xanthines | 1974 |
COMPARATIVE STUDY OF THE EFFECT OF SOME CORONARY DILATORS ON CARDIAC VOLUME.
Topics: Adenosine Triphosphate; Amino Alcohols; Aminophylline; Animals; Cardiac Volume; Dipyridamole; Dogs; Electrocardiography; Heart; Khellin; Muscle Relaxants, Central; Myocardium; Nitrites; Nucleosides; Research; Strophanthins; Theophylline; Tissue Extracts; Tolazoline; Vasodilator Agents | 1963 |
[BASIC TRENDS IN THE SYNTHESIS OF HYPOTENSIVE AGENTS. II].
Topics: Antihypertensive Agents; Bretylium Compounds; Carboxy-Lyases; Dibenzylchlorethamine; Dipyridamole; Guanethidine; Iproniazid; Khellin; Monoamine Oxidase Inhibitors; Phenethylamines; Phenothiazines; Prenylamine; Sympatholytics | 1963 |